Wainberg MA - Search Results

1

Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.

Rübsamen-Waigmann H, Huguenel E, Paessens A, Kleim JP, Wainberg MA, Shah A. Rübsamen-Waigmann H, et al. Among authors: wainberg ma. Lancet. 1997 May 24;349(9064):1517. doi: 10.1016/S0140-6736(97)24021-3. Lancet. 1997. PMID: 9167463 Clinical Trial. No abstract available.

2

Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro.

Rübsamen-Waigmann H, Huguenel E, Shah A, Paessens A, Ruoff HJ, von Briesen H, Immelmann A, Dietrich U, Wainberg MA. Rübsamen-Waigmann H, et al. Among authors: wainberg ma. Antiviral Res. 1999 May;42(1):15-24. doi: 10.1016/s0166-3542(99)00010-8. Antiviral Res. 1999. PMID: 10333139 Clinical Trial.

3

Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.

Friedman SR, Wainberg MA, Drucker E. Friedman SR, et al. Among authors: wainberg ma. AIDS. 1998 Nov 12;12(16):2089-93. doi: 10.1097/00002030-199816000-00003. AIDS. 1998. PMID: 9833849 Review. No abstract available.

4

Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.

Foli A, Maserati R, Minoli L, Wainberg MA, Gallo RC, Lisziewicz J, Lori F. Foli A, et al. Among authors: wainberg ma. AIDS. 1998 Jun 18;12(9):1113-4. AIDS. 1998. PMID: 9662215 No abstract available.

5

Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?

Youle M, Wainberg MA. Youle M, et al. Among authors: wainberg ma. AIDS. 2003 Apr 11;17(6):937-8. doi: 10.1097/00002030-200304110-00027. AIDS. 2003. PMID: 12660549 No abstract available.

6

Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention.

Gupta RK, Van de Vijver DA, Manicklal S, Wainberg MA. Gupta RK, et al. Among authors: wainberg ma. Retrovirology. 2013 Jul 31;10:82. doi: 10.1186/1742-4690-10-82. Retrovirology. 2013. PMID: 23902855 Free PMC article. Review.

7

New findings on blockage of HIV-1 RNase H activity.

Wainberg MA. Wainberg MA. AIDS. 2009 Jan 14;23(2):223-4. doi: 10.1097/QAD.0b013e32831c5526. AIDS. 2009. PMID: 19098492 No abstract available.

8

Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns.

Lisziewicz J, Foli A, Wainberg M, Lori F. Lisziewicz J, et al. Drug Saf. 2003;26(9):605-24. doi: 10.2165/00002018-200326090-00002. Drug Saf. 2003. PMID: 12814330 Review.

9

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study.

Phillips AN, Cambiano V, Nakagawa F, Revill P, Jordan MR, Hallett TB, Doherty M, De Luca A, Lundgren JD, Mhangara M, Apollo T, Mellors J, Nichols B, Parikh U, Pillay D, Rinke de Wit T, Sigaloff K, Havlir D, Kuritzkes DR, Pozniak A, van de Vijver D, Vitoria M, Wainberg MA, Raizes E, Bertagnolio S; Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa. Phillips AN, et al. Among authors: wainberg ma. Lancet HIV. 2018 Mar;5(3):e146-e154. doi: 10.1016/S2352-3018(17)30190-X. Epub 2017 Nov 22. Lancet HIV. 2018. PMID: 29174084 Free PMC article.

10

Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy.

Youle M, Wainberg MA. Youle M, et al. Among authors: wainberg ma. J Int Assoc Physicians AIDS Care (Chic). 2003 Jul-Sep;2(3):102-5. doi: 10.1177/154510970300200302. J Int Assoc Physicians AIDS Care (Chic). 2003. PMID: 14556428 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

686 results

Search Page

Filters